Thompson Siegel & Walmsley LLC Gsk PLC Transaction History

Thompson Siegel & Walmsley LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$42.05 - $47.77 $3.72 Million - $4.22 Million	-88,400 Reduced 42.1%	121,600 $5.29 Million
Q1 2022 Apr 26, 2022	BUY	$40.23 - $47.74 $1.04 Million - $1.23 Million	25,750 Added 13.98%	210,000 $9.15 Million
Q4 2021 Feb 09, 2022	BUY	$38.88 - $45.31 $583,200 - $679,650	15,000 Added 8.86%	184,250 $8.13 Million
Q3 2021 Nov 05, 2021	BUY	$38.79 - $43.16 $1.32 Million - $1.47 Million	33,950 Added 25.09%	169,250 $6.47 Million
Q2 2021 Aug 09, 2021	BUY	$36.52 - $41.46 $3.7 Million - $4.2 Million	101,400 Added 299.12%	135,300 $5.39 Million
Q1 2021 May 07, 2021	SELL	$34.27 - $40.01 $33,002 - $38,529	-963 Reduced 2.76%	33,900 $1.21 Million
Q2 2020 Aug 11, 2020	BUY	$37.87 - $43.58 $1.28 Million - $1.48 Million	33,900 Added 3520.25%	34,863 $1.42 Million
Q3 2017 Nov 08, 2017	SELL	$39.44 - $41.55 $31,552 - $33,240	-800 Reduced 45.38%	963 $39,000
Q2 2017 Aug 09, 2017	BUY	N/A	1,763	1,763 $76,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.